A new chapter in infection prevention is here—and Surfacide is helping to define it.
In a newly launched video series from Infection Control Today, Surfacide Founder & CEO Gunner Lyslo joins IFC’s Tori Whitacre Martonicz to discuss the FDA’s creation of the Whole Room Microbial Reduction (WRMR) category and what it means for the future of UV-C in healthcare settings.
Hit the play button below to watch Part 1:
“FDA Clearance Marks a New Era for UVC Disinfection in Health Care”
The conversation explores the critical need for FDA oversight in a space that has long operated without it—and how this shift brings clarity and higher standards for hospitals, environmental services teams, and infection prevention leaders.
Key topics include:
- What FDA clearance for UV-C devices actually means
- Why hospitals should prioritize FDA-authorized systems
- What hospital decision-makers and IP leaders should know when evaluating UV-C technology
As one of the first companies to receive FDA clearance under the WRMR classification, Surfacide continues to lead with science, transparency, and proven performance.
Stay tuned for more interviews in the series—and learn why choosing an FDA-authorized UV-C system is no longer optional.
